The nuclear pharmacist must have completed such additional training and must demonstrate such additional qualifications in the practice of nuclear pharmacy as is required by the board by rule in addition to licensure as a registered pharmacist. The board shall adopt rules necessary to implement and administer this section.
The requirements of this section do not apply to hospitals licensed under chapter or the nuclear medicine facilities of such hospitals. All such delegated acts must be performed under the direct supervision of a licensed pharmacist who is responsible for all such acts performed by persons under his or her supervision. A registered pharmacy technician, under the supervision of a pharmacist, may initiate or receive communications with a practitioner or his or her agent, on behalf of a patient, regarding refill authorization requests.
- The Harvard Psychedelic Club : how Timothy Leary, Ram Dass, Huston Smith, and Andrew Weil killed the fifties and ushered in a new age for America?
- Evolutions Darling.
- .NET Security and Cryptography?
A licensed pharmacist may not supervise more than one registered pharmacy technician unless otherwise permitted by the guidelines adopted by the board. The board shall establish guidelines to be followed by licensees or permittees in determining the circumstances under which a licensed pharmacist may supervise more than one pharmacy technician. Notwithstanding any requirements in this subsection, any registered pharmacy technician registered pursuant to this section before January 1, , who has worked as a pharmacy technician for a minimum of 1, hours under the supervision of a licensed pharmacist or received certification as a pharmacy technician by certification program accredited by the National Commission for Certifying Agencies is exempt from the requirement to complete an initial training program for purposes of registration as required by this subsection.
A pharmacy technician student shall wear identification that indicates his or her student status when performing the functions of a pharmacy technician, and registration under this section is not required. The board may adopt other rules as necessary to administer this section. Any pharmacist who knowingly fails to make such a report within 24 hours after learning of the fraud or attempted fraud or at the close of business on the next business day, whichever is later, commits a misdemeanor of the first degree, punishable as provided in s.
A sufficient report of the fraudulent obtaining of controlled substances under this subsection must contain, at a minimum, a copy of the prescription used or presented and a narrative, including all information available to the pharmacist concerning the transaction, such as the name and telephone number of the prescribing physician; the name, description, and any personal identification information pertaining to the person who presented the prescription; and all other material information, such as photographic or video surveillance of the transaction.
This paragraph shall not preclude a person not licensed as a pharmacist from owning a pharmacy. Hold himself or herself out to others as a person, firm, or corporation licensed or registered to practice pharmacy in this state. Any person who violates any provision of subsection 2 commits a felony of the third degree, punishable as provided in s. In any warrant, information, or indictment, it shall not be necessary to negative any exceptions, and the burden of any exception shall be upon the defendant.
If the person does not have proper identification, the pharmacist may verify the validity of the prescription and the identity of the patient with the prescriber or his or her authorized agent. Verification of health plan eligibility through a real-time inquiry or adjudication system is considered to be proper identification. This disclosure shall be made within 30 days after any change of location, corporate officer, or pharmacist serving as the prescription department manager for dispensing medicinal drugs to residents of this state;.
It shall respond directly to all communications from the board concerning emergency circumstances arising from errors in the dispensing of medicinal drugs to the residents of this state;. This toll-free number must be disclosed on the label affixed to each container of dispensed medicinal drugs.
Pharmacy Law and Practice by Merrills
The board may require such information as the board deems reasonably necessary to carry out the purposes of this section. The board may grant an exemption from the registration requirements of this section to any nonresident pharmacy which confines its dispensing activity to isolated transactions. The board may define by rule the term isolated transactions. The board may require an applicant to provide any information it deems reasonably necessary to carry out the purposes of this section. The attestor has read and understands the laws and rules governing the manufacture, distribution, and dispensing of prescription drugs in this state.
A prescription drug product shipped, mailed, or delivered into this state must not have been, and may not be, manufactured or distributed in violation of the laws and rules of the jurisdiction in which the applicant is located and from which the prescription drugs shall be exported.
The inspection report must reflect compliance with this section. An inspection report is current if the inspection was conducted within 6 months before the date of submitting the application for the initial permit or within 1 year before the date of submitting an application for permit renewal. If the applicant is unable to submit a current inspection report conducted by the regulatory or licensing agency of the jurisdiction in which the applicant is located and from which the prescription drugs will be exported, due to acceptable circumstances, as established by rule, or if an inspection has not been performed, the department must: 1.
Conduct, or contract with an entity to conduct, an onsite inspection, with all related costs borne by the applicant;. Accept a current and satisfactory inspection report, as determined by rule, from an entity approved by the board; or. The rules must establish, at a minimum, financial reporting requirements, standards for financial capability to perform the functions governed by the permit, and requirements for ensuring permittees and their contractors can be held accountable for the financial consequences of any act of malfeasance or misfeasance or fraudulent or dishonest act or acts committed by the permittee or its contractors.
The board may require such information as it deems reasonably necessary to carry out the purposes of this section. The fee for an initial permit and biennial renewal of the permit shall be set by the board pursuant to s.
Pharmacy Practice and the Law by Richard R. Abood
The attestor has read and understands the laws and rules governing sterile compounding in this state. A compounded sterile product shipped, mailed, delivered, or dispensed into this state must not have been, and may not be, compounded in violation of the laws and rules of the state, territory, or district in which the applicant is located. If the applicant is unable to submit a current inspection report conducted by the regulatory or licensing agency of the state, territory, or district in which the applicant is located, due to acceptable circumstances, as established by rule, or if an inspection has not been performed, the department shall: 1.
Conduct, or contract with an entity to conduct, an onsite inspection for which all costs shall be borne by the applicant;. Habitual intoxication. The misuse or abuse of any medicinal drug appearing in any schedule set forth in chapter Any abnormal physical or mental condition which threatens the safety of persons to whom she or he might sell or dispense prescriptions, drugs, or medical supplies or for whom she or he might manufacture, prepare, or package, or supervise the manufacturing, preparation, or packaging of, prescriptions, drugs, or medical supplies.
A plea of nolo contendere constitutes a conviction for purposes of this provision. For purposes of this paragraph, it shall be legally presumed that the compounding, dispensing, or distributing of legend drugs in excessive or inappropriate quantities is not in the best interests of the patient and is not in the course of the professional practice of pharmacy. Such reports or records include only those which the licensee is required to make or file in her or his capacity as a licensed pharmacist. Nothing in this section shall be construed to prohibit the quotation of price information on a prescription drug to a potential consumer by telephone.
Each pharmacist shall maintain appropriate records for any unused or returned medicinal drugs. A pharmacist affected under this paragraph shall at reasonable intervals be afforded an opportunity to demonstrate that she or he can resume the competent practice of pharmacy with reasonable skill and safety to her or his customers. However, a person who the licensee knows is unable to practice medicine or osteopathic medicine with reasonable skill and safety to patients by reason of illness or use of alcohol, drugs, narcotics, chemicals, or any other type of material, or as a result of a mental or physical condition, may be reported to a consultant operating an impaired practitioner program as described in s.
Receiving, interpreting, or clarifying a prescription. Verifying or validating a prescription. Performing pharmaceutical calculations. Performing prospective drug review as defined by the board. Obtaining refill and substitution authorizations. Interpreting or acting on clinical data.
Performing therapeutic interventions. Providing patient counseling. Such guidelines may include minimum and maximum fines, periods of supervision or probation, or conditions of probation or reissuance of a license. Such rules must be consistent with the duty to preserve the confidentiality of such records in accordance with applicable state and federal law. No permit shall be issued unless a licensed pharmacist is designated as the prescription department manager. If the transferor fails to repay or make arrangements to repay the amounts owed to the department, the license or registration may not be issued to the transferee until repayment or until arrangements for repayment are made.
The department must make the inspection within 90 days before issuance of the permit. If the board certifies that the application complies with the laws of the state and the rules of the board governing pharmacies, the department shall issue the permit. No medicinal drugs may be dispensed in a Class I institutional pharmacy. However, an institutional pharmacy located in an area or county included in an emergency order or proclamation of a state of emergency declared by the Governor may provide dispensing and consulting services to individuals who are not patients of the institution.
The obtaining and administering of such single dose of a medicinal drug shall be pursuant to drug-handling procedures established by a consultant pharmacist. Medicinal drugs may be dispensed in a Class II institutional pharmacy, but only in accordance with the provisions of this section. Class III institutional pharmacies may also: a. Dispense, distribute, compound, and fill prescriptions for medicinal drugs.
Prepare prepackaged drug products. Conduct other pharmaceutical services for the affiliated hospital and for entities under common control that are each permitted under this chapter to possess medicinal drugs. Provide the services in sub-subparagraphs a. A Class III institutional pharmacy shall maintain policies and procedures addressing: a.
etligati.gq The consultant pharmacist responsible for pharmaceutical services. Safe practices for the preparation, dispensing, prepackaging, distribution, and transportation of medicinal drugs and prepackaged drug products. Recordkeeping to monitor the movement, distribution, and transportation of medicinal drugs and prepackaged drug products. Recordkeeping of pharmacy staff responsible for each step in the preparation, dispensing, prepackaging, transportation, and distribution of medicinal drugs and prepackaged drug products.
Medicinal drugs and prepackaged drug products that may not be safely distributed among Class III institutional pharmacies. Such dispensing from the emergency department must be in accordance with the procedures of the hospital. For any such patient for whom a medicinal drug is warranted for a period to exceed 24 hours, an individual licensed to prescribe such drug must dispense a hour supply of such drug to the patient and must provide the patient with a prescription for such drug for use after the initial hour period.
The board may adopt rules necessary to carry out the provisions of this subsection. Every institutional pharmacy that employs or otherwise uses registered pharmacy technicians shall have a written policy and procedures manual specifying those duties, tasks, and functions that a registered pharmacy technician is allowed to perform. A facility with a Class II or Class III institutional pharmacy permit which is operating under the formulary system shall establish policies and procedures for the development of the system in accordance with the joint standards of the American Hospital Association and American Society of Hospital Pharmacists for the utilization of a hospital formulary system, which formulary shall be approved by the medical staff.
- See a Problem?.
- Geometry of Banach spaces: Selected topics!
- Gaussian Random Functions.
- The Bush Doctrine and the war on Terrorisn: Global Reactions, Global Consequences.
- Pharmacy Education Series.
If the board certifies that the application complies with applicable law, the department shall issue the permit. No permit shall be issued unless a duly licensed and qualified nuclear pharmacist is designated as being responsible for activities described in s. The permittee shall notify the department within 10 days of any change of the licensed pharmacist responsible for the compounding and dispensing of nuclear pharmaceuticals.